Showing results (71-80 of 382) with videos related to
Sort By:
Pageof 39
Science Translational Medicine|June 8, 2022
A step forward for LRRK2 inhibitors in Parkinson's diseasePatrick A LewisBiology of the Cell|January 21, 2009
The function of ROCO proteins in health and diseasePatrick A LewisScientific Reports|October 13, 2016
mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1Claudia Manzoni, Adamantios Mamais, Dorien A Roosen, et al.The FEBS Journal|November 22, 2008
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body diseaseJose Bras, Andrew Singleton, Mark R Cookson, et al.The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 28, 2004
Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's diseaseMelisa J Baptista, Mark R Cookson, David W MillerBiochemical Society Transactions|July 31, 2024
Mechanisms of lysosomal tubulation and sorting driven by LRRK2Luis Bonet-Ponce, Jillian H Kluss, Mark R CooksonThe Biochemical Journal|January 27, 2016
The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical researchRebekah G Langston, Iakov N Rudenko, Mark R CooksonCurrent Protein & Peptide Science|March 12, 2016
The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their PathogenicityDavid N Hauser, Christopher T Primiani, Mark R CooksonNeuron Glia Biology|April 15, 2006
Glial cell inclusions and the pathogenesis of neurodegenerative diseasesDavid W Miller, Mark R Cookson, Dennis W DicksonThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 10, 2014
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesGaia Skibinski, Ken Nakamura, Mark R Cookson, et al.Pageof 39